MiR-199-3p promotes ERK-mediated IL-10 production by targeting poly (ADP-ribose) Polymerase-1 in patients with systemic lupus erythematosus
- 1 June 2019
- journal article
- research article
- Published by Elsevier in Chemico-Biological Interactions
- Vol. 306, 110-116
Abstract
No abstract availableKeywords
Funding Information
- Zhejiang Science and Technology Bureau (2016C33214)
- Natural Science Foundation of China (LY15H100004)
- National Natural Science Foundation of China (31470849)
This publication has 38 references indexed in Scilit:
- Role of interleukin-10 and interleukin-10 receptor in systemic lupus erythematosusClinical Rheumatology, 2013
- Roles for MicroRNAs in Conferring Robustness to Biological ProcessesCell, 2012
- Roles of Pro- and Anti-Inflammatory Cytokines in the Pathogenesis of SLEJournal of Biomedicine and Biotechnology, 2012
- PARP Activity and NAD Concentration in PMC from Patients Affected by Systemic Sclerosis and Lupus ErythematosusNucleosides, Nucleotides & Nucleic Acids, 2010
- Identification of Unique MicroRNA Signature Associated with Lupus NephritisPLOS ONE, 2010
- Interleukin 10 acts on regulatory T cells to maintain expression of the transcription factor Foxp3 and suppressive function in mice with colitisNature Immunology, 2009
- PARP-1-induced cell death through inhibition of the MEK/ERK pathway in MNNG-treated HeLa cellsApoptosis, 2007
- The PARP superfamilyBioEssays, 2004
- Reciprocal CD40 signals through p38MAPK and ERK-1/2 induce counteracting immune responsesNature Medicine, 2004
- Altered metabolism of poly(adp‐ribose) in the peripheral blood lymphocytes of patients with systemic lupus erythematosusArthritis & Rheumatism, 1989